Standard Operating Procedure for Pre-Study Kickoff Meeting Conduct in BA/BE Studies
| Department | BA-BE Studies |
|---|---|
| SOP No. | SOP/BA-BE/034/2025 |
| Supersedes | SOP/BA-BE/034/2022 |
| Page No. | Page 1 of 12 |
| Issue Date | 17/04/2025 |
| Effective Date | 20/04/2025 |
| Review Date | 17/04/2026 |
1. Purpose
To define the procedure for conducting a pre-study kickoff meeting for Bioavailability/Bioequivalence (BA/BE) studies to ensure that all relevant stakeholders are aligned on study objectives, timelines, roles, and responsibilities prior to study initiation.
2. Scope
This SOP applies to all BA/BE studies coordinated or sponsored by the organization and involves all departments and stakeholders participating in study execution including Clinical, QA, Regulatory, Medical, Data Management, Pharmacovigilance,
3. Responsibilities
- Clinical Project Manager: Responsible for organizing and leading the pre-study kickoff meeting.
- Functional Department Heads: Present functional area responsibilities and confirm resource availability.
- Quality Assurance: Provides input on compliance expectations and audit readiness.
- Regulatory Affairs: Updates on submission status, approvals, and timelines.
4. Accountability
The Head of Clinical Operations is accountable for ensuring a formal pre-study kickoff meeting is conducted and documented for every BA/BE study prior to first subject screening.
5. Procedure
5.1 Meeting Planning and Scheduling
- Schedule the kickoff meeting at least 2 weeks before the planned first subject screening date.
- Circulate meeting invitation to all relevant stakeholders using Annexure-1: Kickoff Meeting Attendance List.
- Prepare agenda using Annexure-2: Pre-Study Kickoff Agenda Template.
5.2 Meeting Content
- The meeting must include discussion on the following:
- Study objectives and overview
- Study design (cross-over/parallel/fed/fasted)
- Roles and responsibilities
- Protocol highlights and critical procedures
- Informed consent and EC submission status
- Clinical supplies availability and randomization codes
- Data management and CRF tracking
- Adverse event reporting workflow
- Quality assurance checks and audit timelines
- Risk mitigation strategies
5.3 Documentation and Follow-Up
- Record meeting minutes in Annexure-3: Kickoff Meeting Minutes Log.
- Track open action items with responsible persons and deadlines in Annexure-4: Action Item Tracker.
- Distribute signed attendance sheet and meeting minutes to all participants.
- File documents in TMF and archive electronically.
6. Abbreviations
- BA: Bioavailability
- BE: Bioequivalence
- CRF: Case Report Form
- TMF: Trial Master File
- EC: Ethics Committee
- CRO: Contract Research Organization
7. Documents
- Kickoff Meeting Attendance List – Annexure-1
- Pre-Study Kickoff Agenda Template – Annexure-2
- Kickoff Meeting Minutes Log – Annexure-3
- Action Item Tracker – Annexure-4
8. References
- ICH E6(R2) – Good Clinical Practice
- CDSCO Guidance on Clinical Trial Management
- Organization’s Clinical Study Management Policy
9. SOP Version
Version: 2.0
10. Approval Section
| Prepared By | Checked By | Approved By | |
|---|---|---|---|
| Signature | |||
| Date | |||
| Name | |||
| Designation | |||
| Department |
11. Annexures
Annexure-1: Kickoff Meeting Attendance List
| Name | Department | Designation | Signature | |
|---|---|---|---|---|
| Rajesh Kumar | Clinical | Project Manager | rajesh.k@domain.com |
Annexure-2: Pre-Study Kickoff Agenda Template
| Agenda Item | Presenter | Time Allocated |
|---|---|---|
| Study Overview & Objectives | Meera Shah | 10 min |
Annexure-3: Kickoff Meeting Minutes Log
| Date | Meeting Summary | Prepared By | Reviewed By |
|---|---|---|---|
| 16/04/2025 | Study BE-040 team aligned on FPFV plan | Sunita Reddy | Dr. Arvind Shah |
Annexure-4: Action Item Tracker
| Action Item | Owner | Due Date | Status |
|---|---|---|---|
| Submit EC approval letter to TMF | Regulatory Affairs | 18/04/2025 | Pending |
Revision History:
| Revision Date | Revision No. | Details | Reason | Approved By |
|---|---|---|---|---|
| 15/01/2022 | 1.0 | Initial SOP | New documentation | QA Head |
| 17/04/2025 | 2.0 | Added annexures and clarified attendee responsibilities | Operational standardization | QA Head |